Participant timeline | Week | − 8 > | − 2 | − 1 | 0 | 4 | 12 | 17 | 18 | 18 |
---|---|---|---|---|---|---|---|---|---|---|
Domain | Visit 0 | Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | Visit 8 | |
Intervention period | X | X | X | |||||||
Primary outcome | ||||||||||
Hyperglycaemic clamp | β-cell function | X | X | |||||||
Secondary and exploratory outcomes | ||||||||||
Clinical blood sampling | Clinical, functional, metabolic markers of mechanisms1 | X | X | X | X | X | ||||
Urine sampling | Systemic markers of oxidative stress2 | X | X | X | X | |||||
Mixed meal tolerance test | Glycaemic control during mixed meal tolerance test3 | X | X | |||||||
Continuous glucose monitoring | 24-h glucose profile | X | X | |||||||
Muscle and fat biopsies | Muscle and fat profiling4 | X | X | |||||||
Cardiovascular procedures | ||||||||||
Home blood pressure | Resting systolic and diastolic blood pressure | X | X | X | X | |||||
Body composition | ||||||||||
Magnetic resonance imaging | Visceral fat mass | X | X | |||||||
Magnetic resonance spectroscopy | Pancreatic and hepatic fat deposition | X | X | |||||||
Dual-energy X-ray absorptiometry | BW, BMI, LBM, FM | X | X | |||||||
Physical function | ||||||||||
Cardiorespiratory fitness | Maximal aerobic capacity | X | X | |||||||
Muscular strength | 1RM | X | X | |||||||
Physical activity behaviour | Accelerometer-based physical activity monitors | X | X | X | X | |||||
Patient-reported outcomes | ||||||||||
Mental and physical well-being | SF36 questionnaire | X | X | |||||||
Quality of life | SF36 questionnaire | X | X | |||||||
Satiety | VAS | X | X | |||||||
Dietary records | 3-day record | X | X | X | X |